[e-drug] Court ruling in Kenya a victory for access to medicines

E-DRUG: Court ruling in Kenya a victory for access to medicines
-----------------------------------------------------
[This is welcome news. Moderator]

23 April 2010, Nairobi

Health Action International (HAI) Africa welcomes today's ruling by High
Court Judge Roseline Wendo stopping the Kenyan government from implementing
the Anti-Counterfeit Act, 2008 with respect to generic medicines, until a
case filed in July 2009 by three people living with HIV is heard and
determined.

The petitioners are seeking to have the the A-C Act 2008 declared
unconstitutional on the grounds that it infringes on their right to life by
giving a broad definition and interpretation of what constitutes
counterfeit medicines. The petitioners argue this threatens their access to
generic medicines and right to life.

The High Court ruling means that the Anti-Counterfeit Agency cannot
interfere with the importation and distribution of generic medicines which
are widely used in Kenya’s health system, including the national treatment
programme for those living with HIV.

“This ruling keeps the window of opportunity open for those in need of more
affordable generic medicines. While the constitutional court case is yet to
be fully determined, this ruling has reinforced the peoples' call that
public interest and human rights must be carefully considered before
enacting and implementing any law,” said Gichinga Ndirangu, Regional
Coordinator, HAI Africa.

It is not known when the case will be heard and determined in full but the
Constitutional Court will give hearing dates in due course.

“We view this ruling as a clear recognition of the dangers to public health
in the anti-counterfeiting movement," Mr Ndirangu added, "and as a
significant step in the peoples' fight for the right to health and the
struggle for access to essential medicines for all Kenyans."

HAI Africa
info@haiafrica.org
www.haiafrica.org

E-DRUG: Sources and prices of selected medicines for children (2nd edition)
--------------------------------------------------------------------------
[This updated, 2nd edition lists sources and prices for 75% of the 612 formulations needed for the 240 medicines in the Essential Medicines List for Children.

Of special interest is that dispersable tablets are now available that are far much cheaper than the traditional liquid preparations. I think this is a trend that all E-druggers should note!

We however still have neglected medicines for children: UNICEF and WHO could not find a manufacturer for 144 of the 612 needed formulations. Is it lack of commercial markets? Or is it that there is not yet enough demand? Here is a good opportunity for the pharmaceutical industry to show some corporate social responsibility!

WB]

COPENHAGEN, 28 April 2010 - The second edition of Sources and Prices of Selected Medicines for Children is now available.

http://www.who.int/medicines/publications/essentialmedicines/Sources_Prices2010.pdf

The guide, published annually by UNICEF and WHO, offers up-to-date information on the availability and price of 240 drug items in 612 different paediatric formulations selected from the ‘WHO Model List of Essential Medicines for Children’, including therapeutic food, and vitamin and mineral supplements, to treat major childhood illnesses and disease. The information is vital for development and health partners involved in policy and programme planning who procure and supply essential medicines for children.

75% of the formulations included are available for purchase. For the remaining 25%, sourcing remains a challenge. The guide ranks the availability of the identified medicines. Sources for children’s medicines and treatments to address opportunistic infections, palliative care, pain and pneumonia had good coverage. Coverage of paediatric formulations for treatments of malaria, maternal and newborn care, and tuberculosis was fair. However, the number of sources is limited for the paediatric treatment of diarrhoea and HIV/AIDS, and remains a serious challenge for child-specific medicines to treat tropical infections endemic in Africa and Asia.

“While effective medicines exist to fight disease and treat life-threatening conditions like malnutrition, formulations suitable for children are often difficult to source,” said Francisco Blanco, Chief of Medicines & Nutrition, UNICEF Supply Division. “The data in this edition confirms that much more research and effort needs to be made to make medicines for children more available and accessible for those who need them most.”

“An estimated 9 million children die each year from preventable and treatable causes. Improved availability and access to safe child-specific medicines is still far from reality for many children in poor countries. This one-of-its-kind publication will be useful for organizations and personnel involved in procurement to identify where medicines may be found and what they cost,” said Hans Hogerzeil, Director Essential Medicines and Pharmaceutical Policies at WHO.

Key points from 2010 edition

* WHO recommends that wherever possible, medicines for children should be provided as flexible, solid, oral dosage forms that can be administered in a liquid when it is given to the sick child. Liquid formulations are more expensive to purchase compared with dispersible tablets and are also more costly to store, package, and transport safely.

*Although diseases such as schistosomiasis, filariasis, and parasites transmitted through soil, are endemic in some parts of Africa and Asia, there remain very few manufacturers who produce child-specific medicines to treat these neglected diseases. Broadening the market search for essential medicines in this category is a serious challenge.

*Newborn care is often lacking in poor countries, particularly in hard to reach communities. At the time of publication, there was no information from manufacturers for respiratory stimulants and pulmonary surfactants for the treatment of apnoea and respiratory distress syndrome in newborns.

*Sources and Prices of Selected Medicines for Children is part of UNICEF/WHO work to make essential medicines for children more universally available. Since the launch of the campaign “Make Medicines Child Size” in 2007, WHO and UNICEF have been working in partnership to raise awareness and accelerate action to address the serious gaps that contribute to nine million preventable child deaths every year.

Note for manufacturers

UNICEF and WHO invite manufacturers to submit products to be added to the data base. Please refer to the report for minimum criteria for inclusion. Please note: the products and manufacturers in this report are not necessarily prequalified or endorsed by UNICEF and WHO. Contact: supply@unicef.org for more information.

Links

UNICEF: http://www.unicef.org/supply/index.html
WHO: http://www.who.int/medicines/publications/Medicinespubarchive/en/index.html

About UNICEF

UNICEF is on the ground in over 150 countries and territories to help children survive and thrive, from early childhood through adolescence. The world’s largest provider of vaccines for developing countries, UNICEF supports child health and nutrition, good water and sanitation, quality basic education for all boys and girls, and the protection of children from violence, exploitation, and AIDS. UNICEF is funded entirely by voluntary contributions.

About WHO

WHO is the directing and coordinating authority for health within the United Nations system. It is responsible for providing leadership on global health matters, shaping the health research agenda, setting norms and standards, articulating evidence-based policy options, providing technical support to countries and monitoring and assessing health trends. The Essential Medicines and Pharmaceutical Policies department's vision is that people everywhere have access to the essential medicines they need; that the medicines are safe, effective and of assured quality; and that they are prescribed and used rationally.

For further information please contact:

Joan Howe, Communications Specialist, UNICEF Supply Division, Copenhagen, Denmark
Mobile: +45 29 65 71 94
jhowe@unicef.org

Liz Finney, Communications Officer, World Health Organization, Geneva, Switzerland
Phone: +41 22 791 1866
finneye@who.int

Links

1.http://www.who.int/medicines/publications/Medicinespubarchive/en/index.html
2.http://www.unicef.org/supply/index.html
3.http://www.unicef.org/supply/index_47129.html?q=printme#
4.http://www.unicef.org/
5.http://www.unicef.org/supply/index_47129.html?q=printme

---
Atieno Ojoo
Technical Specialist, pharmaceuticals
Unicef Supply Division
Unicef Plads, Freeport
2100 Copenhagen
Denmark
Tel; +45 35 27 31 03
Fax: +45 35 26 94 21
Email: aojoo@unicef.org
http//www.unicef.org/supply

E-DRUG: Sources and prices of selected medicines for children (2)
----------------------------------------------------------------

dear WHO and UNICEF,

Thank you very much, this info came at the right time, when the Global Fund was rejecting the prices I used for the PSM Plan.

regards

Matabele Sefali
General Manager
NDSO
Lesotho
gm@ndso.org.ls